Specific role for p300/CREB-binding protein-associated factor activity in E2F1 stabilization in response to DNA...

Area of Science:

• Molecular Biology
• Cell Biology
• Biochemistry

Background:

• E2F1 (E2F transcription factor 1) regulates cell-cycle progression and apoptosis.
• Genotoxic stress typically stabilizes E2F1 via ATM-dependent phosphorylation.
• DNA damage also induces E2F1 acetylation, essential for apoptotic gene promoter recruitment.

Purpose of the Study:

• To investigate E2F1 stabilization mechanisms following DNA damage, independent of canonical pathways.
• To elucidate the role of E2F1 acetylation in response to specific chemotherapeutic agents.
• To differentiate the roles of P/CAF and p300 in E2F1 stabilization and acetylation.

Main Methods:

• Cell treatment with doxorubicin and cisplatin.
• Analysis of E2F1 phosphorylation, acetylation, and protein levels.
• Investigation of E2F1 complex formation with P/CAF and p300.
• Assessment of P/CAF and p300 HAT activity on E2F1 stabilization.

Main Results:

• E2F1 stabilization occurs in response to doxorubicin/cisplatin, even without ATM, p53, or cAbl.
• E2F1 acetylation is required for stabilization by doxorubicin.
• Doxorubicin treatment enhances E2F1-P/CAF complex formation.
• P/CAF HAT activity, not p300 HAT activity, is essential for E2F1 stabilization and accumulation.

Conclusions:

• E2F1 stabilization by DNA damage can occur independently of ATM/p53 signaling.
• Acetylation, particularly via P/CAF HAT activity, plays a critical role in E2F1 stabilization and apoptosis induction.
• P/CAF exhibits a specific role in acetylation-induced E2F1 stabilization during DNA damage response.